glutathione gbm6 patient derived xenograft Patient-Derived Tumor Models: Toward the Establishment of Precision Cancer Medicine International Journal of Oncology
International Journal of Oncology Combined inhibition of de novo glutathione and nucleotide biosynthesis is synthetically lethal in glioblastoma: Cell Reports Frontiers Clinically relevant glioblastoma patient derived xenograft models to guide drug development and identify molecular signatures Patient derived tumour xenografts as models for oncology drug development Nature Reviews Clinical Oncology CHCHD2 mediates glioblastoma cell proliferation, mitochondrial metabolism, hypoxia induced invasion, and therapeutic resistance bioRxiv glutathione gbm6 patient derived xenograft Methionine cycle inhibition disrupts antioxidant metabolism and reduces glioblastoma cell survival Combined inhibition of de novo
Pay in 4 interest-free payments of $5.73 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16





